Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.17766724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Intralesional cidofovir is typically used at concentrations between 5 mg/mL and 7.5 mg/mL for treating recurrent respiratory papillomatosis, but dosing standards and optimal regimens remain variable and not well-established.